Transarterial Chemoembolization (TACE)
Treatment used for 4 conditions
Total Trials
450
Total Participants
70K
Avg Effectiveness
73%
Avg Safety Score
54%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Liver cancer due to hepatitis C
Effectiveness:70%
Safety:60%
Trials:100
Participants:30K
Liver cancer due to alcohol use
Effectiveness:70%
Safety:65%
Trials:100
Participants:15K
Liver cancer due to NASH
Effectiveness:75%
Safety:55%
Trials:200
Participants:15K
Liver cancer due to hepatitis B
Effectiveness:75%
Safety:35%
Trials:50
Participants:10K